Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 août 2026 12h00 HE | Source: American Academy of Anti-Aging Medicine (A4M)

A4M and the International Peptide Society Welcome PCAC Recommendations Supporting Inclusion of Six Reviewed Peptides on the 503A Bulk List

Boca Raton, FL, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The American Academy of Anti-Aging Medicine (A4M) and the International Peptide Society (IPS) today welcomed the recommendation issued by the U.S....
04 août 2026 10h57 HE | Source: Research and Markets

Gene Editing Collaboration and Licensing Deals 2016-2026 | The Definitive Benchmark for Gene Editing Dealmaking

Dublin, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The "Gene Editing Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
27 juil. 2026 08h07 HE | Source: Pluristyx, Inc.

Pluristyx Partners With Leading Regenerative Medicine and Aerospace Pioneers to Standardize Clinical-Grade Hepatocyte Manufacturing for Space and Earth Applications

Pluristyx partners with WFIRM, Innovian Space & ReMDO to scale clinical-grade hepatocyte manufacturing for terrestrial and LEO space bioengineering.
22 juil. 2026 04h39 HE | Source: Research and Markets

Genomic Collaboration and Licensing Deals Report 2018-2026 | Analyze 720+ Genomic Partnerships | Access Contracts and Source Documents

Dublin, July 22, 2026 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2018-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
21 juil. 2026 12h31 HE | Source: Research and Markets

Gene Therapy Collaboration and Licensing Deals Report 2016-2026: Gain Visibility into Partner Behaviour and Recurring Deal Structures

Dublin, July 21, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
21 juil. 2026 12h27 HE | Source: Research and Markets

Stem Cell Collaboration and Licensing Deals Report 2010-2026: A Clear Insight into How Deal Terms Vary by Therapy Type, Development Stage, and Partner Profile

Dublin, July 21, 2026 (GLOBE NEWSWIRE) -- The "Stem Cell Collaboration and Licensing Deals 2010-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive and...
21 juil. 2026 07h02 HE | Source: Axiom Biosciences

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- Axiom Biosciences, a clinical-stage biotechnology company whose lead regenerative therapy produced positive early results in newborns with severe brain...
20 juil. 2026 04h31 HE | Source: Research and Markets

Cancer Monoclonal Antibody Collaboration and Licensing Deals, 2016-2026 | Presents Detailed Analysis of Upfronts, Milestones, and Royalty Structures Across Relevant Deals

Dublin, July 20, 2026 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a...
17 juil. 2026 09h06 HE | Source: Research and Markets

Preclinical Stage Partnering Deals in Pharmaceuticals and Biotechnology 2020-2026: Analyze Over 1,750 Partnering Agreements

Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" has been added to ResearchAndMarkets.com's...
17 juil. 2026 06h48 HE | Source: Research and Markets

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes

Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" has been added to ResearchAndMarkets.com's...

Page suivante